GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Total Liabilities

Senzime AB (OSTO:SEZI) Total Liabilities : kr78.67 Mil (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Total Liabilities?

Senzime AB's Total Liabilities for the quarter that ended in Dec. 2024 was kr78.67 Mil.

Senzime AB's quarterly Total Liabilities declined from Jun. 2024 (kr73.51 Mil) to Sep. 2024 (kr70.21 Mil) but then increased from Sep. 2024 (kr70.21 Mil) to Dec. 2024 (kr78.67 Mil).

Senzime AB's annual Total Liabilities declined from Dec. 2022 (kr60.78 Mil) to Dec. 2023 (kr58.07 Mil) but then increased from Dec. 2023 (kr58.07 Mil) to Dec. 2024 (kr78.67 Mil).


Senzime AB Total Liabilities Historical Data

The historical data trend for Senzime AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Total Liabilities Chart

Senzime AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.55 24.04 60.78 58.07 78.67

Senzime AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.07 56.88 73.51 70.21 78.67

Senzime AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Senzime AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=36.599+(19.042+23.032
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=78.67

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=424.53-345.857
=78.67

Senzime AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=36.599+(19.042+23.032
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=78.67

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=424.53-345.857
=78.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senzime AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Senzime AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.

Senzime AB Headlines

No Headlines